What is RWD/RWE?

Real World Evidence (RWE) is derived from data collected during routine clinical practice. It allows the healthcare stakeholders to analyze the effectiveness of treatment used in patient management based on real life clinical and economic outcomes.

RWE is widely used to support decision-making on the funding of the new medical technologies and informs the clinical and economic rationale underlying the use of specific treatments. That is exactly why the pharmaceutical manufacturers are so much interested in obtaining and using RWE throughout the drug product’s life cycle.

Aston Health combines strategic consulting with collection and assessment of clinical data to construct systems that generate relevant Real World Evidence and perform product (brand) differentiation analysis.

The obtained analytical information makes possible to:

• Improve clinical recommendations
• Streamline patient routing
• Provide rationale to shift public drug purchasing
• Support new drug developments
• Manage the entry of new drugs into healthcare system
• Increase sales by targeting HCPs and develop precise marketing strategies

Aston Health is the leader in RWE-based research in Russia and EEU countries